Fig. 2From: Multi-country clinical practice patterns, including use of biomarkers, among physicians’ treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)Physicians’ (n = 508) considerations when recommending radical cystectomy over BCG treatment (a), and vice versa (b)Back to article page